Automated Hospital Beds Market To Observe Strong Development By 2023

 The Global Automated Hospital Beds Market is expected to register a CAGR of 5.97% and is anticipated to reach USD 2,553.4 million by 2023. 

Automated hospital beds are specially designed for hospitalized patients in need of some form of health care services. These hospitals beds have special features both for the comfort and well-being of the patient and for the convenience of health care workers. Most common features of automated hospital beds are automated adjustable height for the entire bed including the head and the feet, adjustable side rails, and electronic buttons to operate both the bed and other nearby electronic devices.

Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/4250

The increase in the number of various acute and chronic disorders, rising geriatric population, increased number of obese people, continuous development in the designs of the hospital beds for the betterment and more comfort of the patients, and rising healthcare expenditure are the major drivers propelling market growth. However, the high cost of automated hospital beds and expensive maintenance of automated hospital beds are hampering the growth of the market.

Market Dynamics

The rise in the incidence rates of chronic disorders is expected to drive the growth of the market. According to the American Autoimmune Related Diseases Association, in 2017, approximately 50 million Americans were suffering from autoimmune diseases, and more than USD 591 million was spent on research and development of autoimmune disorders. Moreover, the increasing geriatric population, increased number of obese people are also likely to support market growth. On the other hand, the high cost of automated beds and the expensive maintenance of hospital beds is anticipated to hamper the market growth.

Segmentation

The global automated hospital beds market has been segmented into type, technology, type of treatment, usage and end user. By type, the market has been segmented into semi-automatic hospital beds and fully automatic hospital beds. Technology segment has been divided into basic automated hospital beds and smart, automated hospital beds. Based on the type of treatment, the market has been segmented into critical care, acute care, and long-term care. Based on usage, the market has been segmented into general-purpose, intensive care, delivery/birthing, bariatric, pediatric, psychiatric care, pressure relief, and others. By end-user, the market has been segmented hospitals & clinics reproductive care centers, dentistry, home care, and others. The hospitals & clinics segment accounted for a market value of USD  627.4 million in 2016.

Key Players

The prominent players in the global automated hospital beds market are ArjoHuntleigh, Gendron Inc, Hill-Rom Holdings, Invacare Corporation, Linet spol. SRO, Medline Industries, Inc., Stryker Corporation, Paramount Bed Holdings Co., Ltd., and Others.

Regional Analysis

The global automated hospital beds market, based on region, is divided into the Americas, Europe, Asia-Pacific, and the Middle East and Africa.

The European region is estimated to dominate the global automated hospital beds market during the forecast period. This is attributed to the continuous innovation and new product development, moreover, to rise in prevalence of life-threatening diseases, increasing healthcare expenditure and increasing technological advances play a vital role in the growth of the regional market. Furthermore, in an automated hospital beds market, Europe accounted for a market share of 36.0% in 2016. The North America market for automated hospital beds is expected to be the second-largest during the forecast period. Factors such as stable economic conditions and continuously developing technologies and significant investments by hospitals to upgrade their equipment’s including beds is expected to boost the growth of the market in this region. For instance, According to WHO, the North American population is projected to grow by 42% from 2000 to 2050, and so it is imperative that the supply of health care maintains pace with the increased demand

Additionally, the companies operating in the market are mainly concentrating on strategic collaborations and mergers and acquisition, which is expected to support market growth. Asia-Pacific is estimated to be the fastest-growing market due to the increasing incidence of chronic diseases, the government encouragement in the healthcare sector, and growing the working population in the healthcare industry. Furthermore, the market in the Middle East & Africa is expected to witness steady growth due to limited access to healthcare facilities.

Browse More Details of the Report @ https://www.marketresearchfuture.com/reports/automated-hospital-beds-market-4250

Capillary Blood Collection Devices Market - Granular Market Report And Review, 2023

 Global Capillary Blood Collection Devices Market is expected to register a CAGR of 10.3%and is anticipated to reach USD 778.38 Million by 2027. Capillary blood collection devices are well-known technology within blood collection devices. Formerly, these capillary blood collection devices were used for diagnosis of the chronic disease, but nowadays, these capillary devices have wide-range applications. Despite the saturation in developed countries, the market for capillary blood collection devices in healthcare and life science is anticipated to grow.

Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/4213

The increasing prevalence of diabetes, leading to high demand for lancets, favorable medical device regulation, and increasing geriatric population are the major drivers propelling the market growth. However, the risk associated with capillary blood assortment techniques and blood contaminations constrains the growth of the market.

Market Dynamics

The increase in the geriatric population expected to drive the growth of the market. For instance, according to the population reference bureau, the number of Americans aging 65 and older is projected to be more than double from 46 million in 2015 to over 98 million by 2060. Due to the damage or weakening of blood vessels in the geriatric population, capillary blood sampling devices are used so that minimal damage occurs.

Moreover, increasing prevalence of diabetes and growing demand for lancets has fueled the growth of the market. Additionally, favorable medical device regulations are likely to support market growth. On the other hand, the risks related to contamination due to the capillary blood assortment techniques is anticipated to hamper the market growth.

Segmentation

The global capillary blood collection devices market has been segmented into material, type of devices, and end-user. By material, the market has been segregated into plastic, glass, stainless steel, and others.

Based on the type of devices, the market has been divided into blood collecting tubes and collectors, lancets, warming devices, and others.

By end-user, the market has been classified as hospitals & clinics, diagnostic centers and pathology laboratories, home diagnostics, and others. The hospitals & clinics segment accounted for a market value of USD 190.36 million in 2019.

Key Players

The prominent players in the global Capillary Blood Collection Devices market are F. Hoffmann-La Roche AG, Danaher Corporation, Abbott Laboratories, Novo Nordisk AS, Becton Dickinson and Company, Medtronic PLC, B. Braun Melsungen AG, Thermo Fisher Scientific Inc., Terumo Corporation, Ypsomed Holding AG, HTL-STREFA SA, Sarstedt AG & Co, Owen Mumford Ltd, Greiner Bio-One, Improve Medical, and Chengdu Rich Science Industry Co., Ltd.

Some of the key strategies followed by the players operating in the global capillary blood collection devices market were innovation, product development, acquisition, and expansion.

Browse More Details of the Report @ https://www.marketresearchfuture.com/reports/capillary-blood-collection-devices-market-4213

Medical Automation Market Segmentation Detailed Study With Forecast Up To 2023

 The Global Medical Automation Market is expected to register a CAGR of 7.0% and is anticipated to reach USD 42,284.6 million by 2023. Automation is defined as the use of control systems and information technologies to reduce the need for human work in the production of goods and services. In recent years, technological advancements have been incorporated into the medical sector, which drives the growth of the medical automation market.

The increasing prevalence of chronic diseases like cancer, diabetes, and others, growing pharmaceutical & biotechnology sector and increasing demand for robotic surgery and rising healthcare expenditure are the major drivers propelling market growth. However, the high cost of automation and risks associated with robotic surgery, followed by the necessity of physician training are expected to constrain the growth of the market.

Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/5184

Market Dynamics

The increasing prevalence of chronic diseases like cancer, diabetes, and others, along with the growing pharmaceutical & biotechnology sector and rising demand for robotic surgery are the major drivers propelling market growth. For instance, according to a report published by the National Cancer Institute in 2016, approximately 1,685,210 new cases of cancer were diagnosed in the US. Moreover, rising healthcare expenditure is also projected to boost market growth. However, the high cost of automation and risks associated with robotic surgery, followed by the necessity of physician training are expected to constrain the growth of the market.

Segmentation

The global medical automation market has been segmented into type, and end user. By type, the market has been divided into diagnostics & monitoring automation, therapeutic automation, lab & pharmacy automation, and medical logistics & training. Diagnostic & monitoring automation is further segregated into automated imaging, point-of-care testing (POCT), and automated image analysis. Therapeutic automation is further bifurcated into non-surgical automation and surgical automation. Medical logistics & training is also classified as logistics automation and trainers. By end-user, the market has been categorized as hospitals & diagnostic centers, pharmacies, research labs & institutes, and others. The hospitals & diagnostic centers segment accounted for a market value of USD 8,554.7 million in 2016.

Key Players

The prominent players in the global medical automation market are Koninklijke Philips NV (Netherlands), Siemens AG (US), General Electric (US), Medtronic (US), Stryker (US), Danaher (US), and Accuray Incorporated (US).

Some of the key strategies followed by the players operating in the global medical automation market were innovation, product development, acquisition, and expansion.

Regional Analysis

The global medical automation market, based on region, is divided into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The Americas is estimated to dominate the global medical automation market during the forecast period due to increasing demands for medical automation in the presence of the increasing prevalence of diseases like cancer, diabetes, among others.

Moreover, growing biotech and biopharmaceutical sector within the region drives the market during the forecast period. The European market for medical automation is expected to be the second-largest during the forecast period. The increasing per capita healthcare expenditure and rising number of robotic surgical procedures are the drivers fueling the market growth.

Asia-Pacific is estimated to be the fastest-growing market due to the growing biotech and biopharmaceutical factor, increasing patient population, and rising healthcare expenditures along with the increasing demands for the robotic surgery. Moreover, in the Asia-Pacific, South Korea accounted for a market share of 12% in 2016. Furthermore, the market in the Middle East & Africa is expected to witness steady growth due to the presence of the low per capita income and stringent government policies, especially within the African region.

Browse More Details of the Report @ https://www.marketresearchfuture.com/reports/medical-automation-market-5184

Cell Culture Media Market To Show Steady Growth, 2023

 The Global Cell Culture Media Market is expected to register a CAGR of 6.9% and is projected to reach USD 2,070.71 million by 2023. A cell culture media is a growth media designed to support the growth of cells. A cell culture media is composed of the appropriate composition of amino acids, vitamins, inorganic salts, glucose, serum, etc. It may require additional supplementary reagents and sera such as growth factors, hormones, lipids, trace elements, and minerals which are necessary for cell cultures to grow and survive in their incubation environment.

Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/4462

The cell culture media market is driven by the growing pharmaceutical industry, rising biopharmaceutical drugs in the pipeline, increasing prevalence of cancer and infectious diseases, and increasing geriatric population. However, the cost of cell culture media and contamination of media are a threat to the growth of the market.

Market Dynamics

Rising research and development in the pharmaceutical and biotechnology industry is driving the growth of the cell culture media market. For instance, according to a recent survey, the pharmaceutical and biotechnology industry in the US spent a total of USD 102 billion on research and development in 2015. Additionally, according to the National Institute for Health Research, the Association of the British Pharmaceutical Industry (ABPI) invested over Euro 4.1 billion in 2015 just in the UK on R&D, looking for breakthroughs for conditions such as cancer, dementia, and rare genetic diseases. This growing research and development in the field of healthcare are leading to an upward demand for cell culture media.

Segmentation

The global cell culture media market has been segmented into product type, application, and end user. By product type, the market has been segregated into reagents, media, and sera. Based on media, the market has been divided into classical media, stem cell media, serum-free media, and others. The market, based on stem cell media, is further categorized as bone marrow, neural stem cells (NSCs), mesenchymal stem cells (MSCs), and embryonic stem cells (ESCs).

Based on application, the market has been bifurcated into biopharmaceutical, tissue-culture and manufacturing, gene therapy, cytogenetic, and others. By end user, the market has been classified as biopharmaceutical companies, academic and research laboratories, hospitals and diagnostics centers, and others.

Key Players

The major players in the global cell culture media market are Merck KGaA (Germany), Bio-Rad Laboratories, Inc. (US), Thermo Fisher Scientific Inc. (US), Lonza (Switzerland), GE Healthcare (US), Becton, Dickinson and Company (US), HiMedia Laboratories (India), Corning Incorporated (US), PromoCell (Germany), Sera Scandia A/S (Denmark), The Sartorius Group (Germany), and Fujifilm Holdings Corporation (Japan).

Some of the key strategies followed by the players operating in the global cell culture media market were mergers, acquisitions, and new product launches.

Browse More Details of the Report @ https://www.marketresearchfuture.com/reports/cell-culture-media-market-4462

Blockchain in Pharmaceutical Supply Chain Management Market - Granular Market Report And Review, 2024

 Market Scenario

The Global Blockchain in Pharmaceutical Supply Chain Management Market is expected to register a CAGR of 22.5% during the forecast period of 2019 to 2024.

A blockchain solution can make a substantive difference to the pharmaceutical supply chain. At every stage of the supply chain process, barcodes would be scanned and recorded onto a blockchain ledger system which, in sequence, records and creates an audit trail of the drug journey. Sensors can also be combined into the supply chain, with temperature or humidity being noted onto the ledger system. This is most important for drugs requiring fridge storage, such as insulin or expensive, specially manufactured medicines.

Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/8009

Furthermore, through the use of blockchain, the supply chain process of the drugs can become more secure and streamlined. Every delivery can be tracked, with the delivery driver traced through biometric measures. Every checkpoint concerning the drugs supply is recorded and traced via biometric measures, 2d barcode scans, or sensor technology. As the drug is tracked from its manufacturing unit to the patient, the whole of the drug supply chain becomes seamless, precise, audited, and safe.

Segmentation

The global blockchain in pharmaceutical supply chain management is segmented on the basis of application, end user, and region.

On the basis of application, the global blockchain in pharmaceutical supply chain management market is segmented into product traceability, risk and compliance management, payment & settlement, others. The market by end user is segmented into manufacturers, distributors, healthcare providers

Key Players

Some of the key players in the Global Blockchain In Pharmaceutical Supply Chain Management Market are IBM, Microsoft, SAP SE, Oracle, Tibco Software, Auxesis Group, Omnichain, Vechain Foundation, Chainvine, Applied Blockchain, AWS, Huawei, Guardtime, BTL Group, Bitfury, Digital Treasury Corporation, Blockverify, Nodalblock, Peer Ledger, and others.

Regional Market Summary

The global blockchain in pharmaceutical supply chain management market is segmented on the basis of regions: Americas, Europe, Asia-Pacific, and the Middle East & Asia. The Americas account for the major share of the market owing to the well-developed technology, high healthcare expenditure, and the presence of the major pharmaceutical players. Europe accounted for the second largest market, which is followed by Asia-Pacific. Well-developed healthcare infrastructure and higher healthcare funds have driven the European blockchain in pharmaceutical supply chain management market. Asia-Pacific is the fastest growing blockchain in pharmaceutical supply chain management market. Rapidly changing healthcare sector, and the presence of huge opportunities for the development of this market have paved the way for market growth. However, the Middle East and Africa holds the least share in the global blockchain in pharmaceutical supply chain management market. The presence of poor economies and low per capita income, especially within Africa, restrains the growth within the region. A majority of the market share within this region is estimated to be held by the Middle East due to increasing government funding in the healthcare for healthcare, and presence of developed economies like UAE, Kuwait, Dubai, and others.

Browse More Details of the Report @ https://www.marketresearchfuture.com/reports/blockchain-pharmaceutical-supply-chain-management-market-8009

Nanobiosensors in Healthcare Market To Observe Significant Growth By 2024

 Global Nanobiosensors in Healthcare Market is expected to register a CAGR of 9.84% from 2019 to 2024.

Nanotechnology in the biosensor is known as nanobiosensor; biosensors are analytical devices used for detection of chemical and biological substances in the human body. Nanobiosensors are the sensors that are made up of nanomaterials and have dimensions between 1 to 100 nanometers. Nanobiosensors are becoming popular in developed countries. The rising prevalence of diabetes in emerging economies, demand for advanced monitoring systems, and raising awareness about advance nanobiosensors are expected to drive the growth of the market. According to the International Diabetes Federation (IDF), it is estimated that the number of diabetic patients in the Middle East and North Africa (MENA) region will grow by 96% from the year 2013 to 2035, i.e., from 34.6 million to 67.9 million. Moreover, rising R&D spending and collaborative strategies adopted by the top players, such as new product launches and collaborations for product development are contributing to the growth of the market.

Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/7993

The rising cost of nanobiosensors and unfavorable reimbursement policies may hamper the growth of the market during the assessment period.

Nanobiosensors in Healthcare Market Segmentation

The global nanobiosensors in the healthcare market has been segmented on the basis of type, application, end user, and region.

On the basis of type, the market has been classified as optical nanobiosensors, electrochemical nanobiosensors, acoustic nanobiosensors, and others. Based on the application, the market has been segmented into diabetes, immunoassay, cancer, pathogenic bacteria, and others. The market, by end user, has been classified as hospitals and clinics, diagnostic centers, point of care, and others. The electrochemical nanobiosensors segment is expected to hold the largest market share of the nanobiosensors in healthcare market owing to its high sensitivity and real-time detection features. However, based on end user point of care testing segment holds the largest market share due to low complex infrastructure and training.

The market has been segmented, by region, into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The nanobiosensors in the healthcare market in the Americas has further been segmented into North America and South America, with the North America market further divided into the US and Canada.

The European nanobiosensors in the healthcare market has been segmented into Western Europe and Eastern Europe. Western Europe has further been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe.

The nanobiosensors in healthcare market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. The nanobiosensors in healthcare market in the Middle East & Africa has been segmented into the Middle East and Africa.

Nanobiosensors in Healthcare Market Key Players

Some of the key players in the global nanobiosensors in healthcare market are Abbott Point of Care, Inc., F. Hoffman-LA Roche Ltd., Medtronic Inc., Nano-Proprietary, Inc., Lifescan, Inc., Illuminex Corporation, Lifesensors, Inc., ACON Laboratories, Inc., Pharmaco-Kinesis Corporation, Bayer Healthcare AG, Bio-Rad Laboratories, Inc., Biosensors International Pte. Ltd., Sysmex Corporation.

Regional Market Summary

The Americas are likely to dominate the global nanobiosensors in healthcare market owing to the rising prevalence of chronic disorders, initiative by government and regulatory authorities, and demands for advanced technology. According to the report published by the US Department of Health & Human Services, in 2017, around 11.5% of the adult population in the US are diagnosed with heart disease, i.e., 28.2 million.

The European market is expected to be the second largest nanobiosensors in healthcare market. The market growth in this region can be attributed to the government focus to control chronic disease, well-established healthcare infrastructure, and the rising population suffering from cardiovascular disorders. Moreover, government funding and support to the healthcare sector are also expected to boost the growth of the nanobiosensors in healthcare market during the forecast period. According to the European Heart Network, cardiovascular disorders are responsible for 3.9 million deaths in the European Union, which are 45% of the total deaths.

Asia-Pacific is expected to be the fastest-growing nanobiosensors in healthcare market during the forecast period owing to rising diabetes, increasing disposable income, and government initiatives for the development of the healthcare sector. According to the International Diabetes Federation, in 2017, more than 84 million people in South-East Asia were affected by diabetes, and this number is expected to reach 156 million by 2045. Moreover, the government of these countries is open to adopting new technology and the best treatment option from a developed country. According to the International Agency for Research on Cancer, in 2018, India has a prevalence of 173.5 cancer patients per 100,000 population. Moreover, in China, the prevalence rate of cancer was 377.6 patients per 100,000 population in 2018

The market in the Middle East & Africa is expected to hold the smallest share of the global nanobiosensors market due to an underdeveloped healthcare sector, lack of technical knowledge, and poor medical facilities

Browse More Details of the Report @ https://www.marketresearchfuture.com/reports/nanobiosensors-in-healthcare-market-7993

Radiology Services Market, Segments, Growth And Value Chain Analysis 2024

 The global radiology services market accounted for USD 8,102.51 million in 2018 and is expected to register a CAGR of 10.5% during the forecast period (2019–2024).

Radiology is the technology that diagnosis and treat diseases within the human body by using medical imaging. The radiology services are served by the radiologists and experts that are qualified for performing the test and have unique postgraduate medical education in, radiation effects on the human body, radiation safety/protection, appropriate performance and interpretation of quality radiologic, and medical imaging examinations. Radiology services comprise X-Rays, computed tomography (CT), ultrasound, fusion imaging, positron emission tomography (PET), nuclear medicine, and magnetic resonance imaging (MRI). These imaging techniques should be performed after having adequate training and understanding of radiation safety and protection.

Browse Sample of the Report @  https://www.marketresearchfuture.com/sample_request/7904

The rising prevalence of the chronic disease, increasing healthcare expenditure, the emergence of thin client 3D viewers, advancement in radiology technology, rising demand for minimally invasive procedures are expected to drive the growth of the market. Moreover, rising R&D spending and aggressive strategies adopted by the top players, such as new product launches, are contributing to the growth of the market. For instance, In June 2018, FDA has anticipated reclassifying some types of radiology image software analyzers from class III to class II devices for mammography breast cancer, ultrasound breast lesions, and radiograph lung nodules. This will help to reduce the regulatory burden on the medical device industry.

However, the risk of high radiation exposure associated with the devices may hamper the growth of the market during the assessment period.

Segmentation

The global radiology services market has been segmented on the basis of product type, application, technology, end user, and region.

On the basis of product type, the market has been classified as stationary digital radiology systems and portable digital radiology systems. Stationary digital radiology systems have been further segmented into stationary ceiling-mounted systems and floor-to-ceiling mounted system. Based on application, the market has been segmented into cardiovascular imaging, chest imaging, dental imaging, mammography imaging, orthopedic imaging, and others. The market, by technology, has been segmented into computed radiology and direct digital radiology. On the basis of end user, the market has been classified as hospitals, diagnostic centers, and others. The stationary digital radiology segment is expected to hold the largest market share of the radiology services market due to acceptance of stationary systems in hospitals, extensive application, and less exposure to radiation. However, portable digital radiology segment is showing the highest growth rate owing to simplicity in the workflow, low-cost, and proficiency performing complex computational tasks.

The market has been segmented, by region, into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The radiology services market in the Americas has further been segmented into North America and South America, with the North American market divided into the US and Canada.

The European radiology services market has been segmented into Western Europe and Eastern Europe. Western Europe has further been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe. 

The radiology services market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. The radiology services market in the Middle East & Africa has been segmented into the Middle East and Africa.

Key Players

Some of the key players in the global radiology services market are 4ways Healthcare Limited, Cybernet Medical Corporation, Everlight Radiology, Global Diagnostics, Medica Reporting Ltd., Onrad, Inc, Radisphere National Radiology Group Inc., RamSoft Inc., Siemens Healthcare, Telediagnostics Services Pvt. Ltd., Telemedicine Clinic, Teleradiology Solutions Inc, and Virtual Radiology (vRAD).

Browse More Details of the Report @ https://www.marketresearchfuture.com/reports/radiology-services-market-7904